Loading stock data…
NuCana plc (NCNA)
$1.58+0.07 (+4.54%)
After Hours$1.60+0.02 (+1.27%)· Last close Jun 29
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NuCana plc in the Healthcare sector is trading at $1.58 with a market capitalization of $8M. The stock is currently near its 52-week low of $1.33, remaining 46.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$4.78M↓ | -$2.84M↑ | -$3.57M↑ | -$11.63M↓ | -$2.79M |
| Net Income | -$3.87M↓ | -$2.48M↓ | -$281,000↑ | -$24.11M↓ | -$2.47M |
Peer Comparison
JNJUNHPFE
Fundamentals
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs i...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.45M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.02
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.18
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-137.46%
Volume
Today's trading volume
41,619
Recent News
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
European equities traded in the US as American depositary receipts were trending higher late Monday
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European equities traded in the US as American depositary receipts started the week higher late Mond
European Equities Traded in US as ADRs Rise in Thursday Trading
European equities traded in the US as American depositary receipts rose late Thursday morning with t
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week higher late M
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were declining late Wednesday mor